Biosimilars Economics of Innovation Drug Shortages The Cost of Drug Shortages Read more © Timothy Masters at adobe.stock.com
Combination Therapies Value, Affordability, and… Unlocking the Value of Combination Therapies Read more ©Tombaky - stock.adobe.com
Chronic Diseases Value, Affordability, and… Alzheimer's Inequalities in Dementia: Unveiling the Evidence and Forging a Path Towards Greater Understanding Read more © _Kube_ - stock.adobe.com
Combination Therapies Value, Affordability, and… A Framework for Value-aligned Pricing of Combination Therapies Read more
Health Technology Assessment… Value, Affordability, and… How Have HTA Agencies Evolved Their Methods Over Time? Read more
Health Care Systems Value, Affordability, and… Socio-Economic Value of Adult Immunisation Programmes Read more © Photo And Art Panda on stock.adobe.com
Health Technology Assessment… Measuring and Valuing Outcomes Incorporating the Patient Voice in Health Technology Assessment Read more
Health Care Systems Policy, Organisation and… Healthcare System Pressure… Developing a Conceptual Framework of Healthcare System Pressure Read more
Emerging Markets Healthcare and Economics Emerging markets face unique challenges in accessing medicines and medical technologies. Filter results by Theme Select the product option you would like to filter Theme Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making Tag Select the product option you would like to filter Tag Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar Date 1 Select the product option you would like to filter Date Clear Filter Date From Month From Year From Date To Month To Year To January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 Author Select the product option you would like to filter Author Search authors Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Antonella Cardone Stan Jackson Content Type Select the product option you would like to filter Content Type news story insight events podcast bulletin publications Reset Filters Featured Insight July 2022 Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly Read more Insight June 2023 Around The World in HTAs: India – Let All Be Healthy Read more Filter results by Theme Select the product option you would like to filter Theme Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making Tag Select the product option you would like to filter Tag Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar Date 1 Select the product option you would like to filter Date Clear Filter Date From Month From Year From Date To Month To Year To January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 Author Select the product option you would like to filter Author Search authors Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Antonella Cardone Stan Jackson Content Type Select the product option you would like to filter Content Type news story insight events podcast bulletin publications Reset Filters News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast… Read more News March 2019 The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback Read more Insight September 2018 As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda? Read more News May 2018 A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List Read more Emerging Markets Economics of Innovation Health Policy and Regulation A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List” Read more News November 2017 Effect of Religion on the Perception of Health States: A Qualitative Study Read more News May 2017 HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making Read more News January 2017 Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico Read more Emerging Markets Value, Affordability, and… Economic Evaluation Policy Options for Formulary Development in Middle-income Countries Read more Emerging Markets Measuring and Valuing Outcomes Economic Evaluation Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study Read more News August 2016 OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development Read more News October 2015 OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries Read more Load More 01 02 03 04 05
Insight July 2022 Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly Read more
News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast… Read more
News March 2019 The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback Read more
Insight September 2018 As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda? Read more
News May 2018 A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List Read more
Emerging Markets Economics of Innovation Health Policy and Regulation A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List” Read more
News November 2017 Effect of Religion on the Perception of Health States: A Qualitative Study Read more
News May 2017 HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making Read more
News January 2017 Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico Read more
Emerging Markets Value, Affordability, and… Economic Evaluation Policy Options for Formulary Development in Middle-income Countries Read more
Emerging Markets Measuring and Valuing Outcomes Economic Evaluation Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study Read more
News August 2016 OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development Read more
News October 2015 OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries Read more